Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Chronic Obstructive Pulmonary Disease|December 23, 2022
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT TrialVictoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan Martin, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 14, 2024
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data StudyClaus F Vogelmeier, Kai-Michael Beeh, Michael Schultze, et al.
Advances in Therapy|June 29, 2023
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling ApproachDave Singh, Diego Litewka, Rafael Páramo, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 28, 2018
COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitionersWilhelmine Meeraus, Robert Wood, Rafal Jakubanis, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 11, 2019
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT TrialAfisi S Ismaila, Nancy Risebrough, Melanie Schroeder, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 9, 2020
Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish PerspectiveMelanie Schroeder, Nicole Benjamin, Laura Atienza, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 8, 2023
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in EnglandAlexandrosz Czira, Gema Requena, Victoria Banks, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 19, 2023
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in EnglandGema Requena, Alexandrosz Czira, Victoria Banks, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2023
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort StudyAlexandrosz Czira, Shoko Akiyama, Takeo Ishii, et al.
Respiratory Research|September 25, 2023
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort studyAfisi S Ismaila, Kieran J Rothnie, Robert P Wood, et al.
Pageof 8